{
    "Contributors": [
        "Ishani Mondal"
    ],
    "Source": [
        "ade_corpus_v2"
    ],
    "URL": [
        "https://github.com/trunghlt/AdverseDrugReaction/tree/master/ADE-Corpus-V2"
    ],
    "Categories": [
        "Text Categorization"
    ],
    "Reasoning": [],
    "Definition": [
        "The task is to classify whether a given medical case report mentions the presence of an adverse drug reaction. An adverse drug reaction is a harmful or unpleasant reaction to a medical product that predicts hazard from future administration of the product. Classify your answers into non-adverse drug event and adverse drug event."
    ],
    "Input_language": [
        "English"
    ],
    "Output_language": [
        "English"
    ],
    "Instruction_language": [
        "English"
    ],
    "Domains": [
        "Biology -> Clinical Knowledge",
        "Healthcare"
    ],
    "Positive Examples": [
        {
            "input": "A case is reported of a child with fatal pulmonary fibrosis following BCNU therapy.",
            "output": "adverse drug event",
            "explanation": "Here, the child is facing some trouble after undergoing a particular therapy, thereby causing an adverse effect of the therapy."
        },
        {
            "input": "She responded well to Sodium valproate.",
            "output": "non-adverse drug event",
            "explanation": "This is a pretty straightforward remark because it is related to filing taxes with minimal stress and is unrelated to irony or sarcasm."
        }
    ],
    "Negative Examples": [
        {
            "input": "The patient suffered from breathing trouble after taking azithromycin.",
            "output": "serious",
            "explanation": "You are expected to return \"adverse drug event\" or \"non-adverse drug event\". This should be classified as adverse drug event because the patient suffers from an issue after taking in a particular drug."
        },
        {
            "input": "The patient is feeling better at the hospital.",
            "output": "wellness",
            "explanation": "You are expected to return \"adverse drug event\" or \"non-adverse drug event\". This should be classified as non-adverse drug event because no harmful after-effect of any medical intervention has been mentioned."
        },
        {
            "input": "A case is reported of a child with fatal pulmonary fibrosis following BCNU therapy.",
            "output": "non-adverse drug event",
            "explanation": "Here, the child is facing some trouble after undergoing a particular therapy, thereby causing an adverse effect of the therapy. So, it needs to be tagged as adverse drug event instead of non-adverse drug event."
        }
    ],
    "Instances": [
        {
            "id": "task1495-c7dc791c62f748348ad6e0ce02cc5c52",
            "input": "Considerable improvement of myasthenic symptoms was seen in all patients within 3-6 months after the initiation of this therapy.",
            "output": [
                "non-adverse drug event"
            ]
        },
        {
            "id": "task1495-2748cbf927194efc82e5ee54cfccac40",
            "input": "BACKGROUND: Gemcitabine has mild renal toxicity, but cases of gemcitabine-associated hemolytic-uremic syndrome (HUS) have been reported.",
            "output": [
                "adverse drug event"
            ]
        },
        {
            "id": "task1495-6537393d34c1459d9435cfdf4af3d899",
            "input": "A 57-year-old woman developed pulmonary sarcoidosis during therapy with interferon beta for advanced renal cell carcinoma metastatic to mediastinal lymph nodes.",
            "output": [
                "adverse drug event"
            ]
        },
        {
            "id": "task1495-43dbda6bb5d44144ae0d8dfa31fb47f3",
            "input": "METHODS: A retrospective report of the first case of gemcitabine-related HUS, in a patient with metastatic pancreatic adenocarcinoma, treated with a variety of standard therapies in addition to rituximab is presented.",
            "output": [
                "adverse drug event"
            ]
        },
        {
            "id": "task1495-a1e1cd70e95743e582bfffaa946fb5a0",
            "input": "Recently lamivudine has been reported to be effective in suppressing the replication of HBV under such conditions.",
            "output": [
                "non-adverse drug event"
            ]
        },
        {
            "id": "task1495-3e8cb360634d4dd3be1d1aa87061d142",
            "input": "Acute sensorineural hearing loss following intravenous ketoralac administration.",
            "output": [
                "adverse drug event"
            ]
        },
        {
            "id": "task1495-1884a131e35e4b38863fd37b5d708d2f",
            "input": "We report a case of drug-induced Kaposi's sarcoma (KS) on the sole of the right foot in a 71-year-old man, treated for 6 months with corticosteroid therapy (prednisolone 25 mg/day) for pericardial effusion.",
            "output": [
                "adverse drug event"
            ]
        },
        {
            "id": "task1495-c2a8be26f79148a88a64d616174879b3",
            "input": "A 59-year-old female was admitted to Tsukuba University Hospital and diagnosed as IgA-lambda multiple myeloma (stage IIIA).",
            "output": [
                "non-adverse drug event"
            ]
        }
    ],
    "Instance License": [
        "Unknown"
    ]
}